Clinical Trial Update: A Trial to Find and Investigate a Safe Dose of BI 836858 in Combination With Decitabine for Patients With Acute Myeloid Leukemia (AML) [Phase 1, Phase 2]

View source ↗

Summary

A combined Phase 1/2 trial evaluating BI 836858 with decitabine in adults with acute myeloid leukemia has completed, with results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• BI 836858
• Decitabine (Decitabine)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Leukemia, Myeloid, Acute | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-03-19